Literature DB >> 300001

Phagocyte function and cell-mediated immunity in systemic lupus erythematosus.

M Landry.   

Abstract

Lymphocyte, granulocyte, and macrophage function were studied simultaneously in 26 untreated patients with systemic lupus erythematosus (SLE) and 26 matched controls. The overall cellular response, as assessed in vivo by skin tests and sensitization to dinitrochlorobenzene, was diminished in the SLE group. Although T cells were reduced in number in patients with SLE, their function appeared unimpaired, as shown by normal lymphocyte transformation to phytohemagglutinin and bacterial and fungal antigens. The depressed cutaneous reactivity observed in vivo was explained by the finding of major deficits in the efferent limb of cellular immunity. Initial rate of phagocytosis of both polymorphonuclear neutrophils and macrophages was significantly reduced in patients with SLE as compared with normal persons. Because of cell interaction, the presence of an intrinsic macrophage defect in SLE may contribute to the alleged T- and B-cell dysfunction in that disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300001

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  9 in total

1.  Circulating immune complexes and monocyte Fc function in autoimmune diseases.

Authors:  M Kávai; K Lukács; I Sonkoly; K Páloczi; G Szegedi
Journal:  Ann Rheum Dis       Date:  1979-02       Impact factor: 19.103

2.  Correlation of disease activity and Clq-binding immune complexes with the neutrophil inclusions which form in the presence of SLE sera.

Authors:  E R Hurd; H E Jasin; J N Gilliam
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

3.  Anti-SSB/La is one of the antineutrophil autoantibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus.

Authors:  S-C Hsieh; H-S Yu; W-W Lin; K-H Sun; C-Y Tsai; D-F Huang; Y-Y Tsai; C-L Yu
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

4.  A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.

Authors:  H D Perez; M Lipton; I M Goldstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

5.  Neutrophil function in systemic lupus erythematosus and other collagen diseases.

Authors:  H Al-Hadithy; D A Isenberg; I E Addison; A H Goldstone; M L Snaith
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

6.  Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE).

Authors:  N P Hurst; G Nuki; T Wallington
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

7.  Loss of monocyte membrane receptors in patients with SLE.

Authors:  M Kávai; K Lukács; I Sonkoly; I J Jókay; A Berndt; G Szegedi
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

8.  [The immune competence of patients with Crohn's disease (author's transl)].

Authors:  E Tönnesmann; P A Bürkle; B Schäfer; K Federlin
Journal:  Klin Wochenschr       Date:  1979-10-15

Review 9.  Infection and Lupus: Which Causes Which?

Authors:  Sarah Doaty; Harsh Agrawal; Erin Bauer; Daniel E Furst
Journal:  Curr Rheumatol Rep       Date:  2016-03       Impact factor: 4.686

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.